Stereotaxis, Inc.
(NYSE Amex Equities : STXS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 5.63%570.531.0%$896.88m
DHRDanaher Corp. 5.63%265.890.7%$727.06m
ABTAbbott Laboratories 1.17%116.220.8%$666.65m
ISRGIntuitive Surgical, Inc. 1.77%227.250.8%$521.08m
MDTMedtronic Plc -1.20%98.250.6%$490.14m
ALGNAlign Technology, Inc. 2.82%282.596.4%$386.05m
BSXBoston Scientific Corp. 2.18%41.021.0%$385.65m
IDXXIDEXX Laboratories, Inc. 3.05%396.673.8%$372.00m
SYKStryker Corp. 0.69%236.561.3%$346.85m
EWEdwards Lifesciences Corp. 2.02%100.560.4%$323.24m
DXCMDexCom, Inc. 2.40%287.387.7%$318.97m
BDXBecton, Dickinson & Co. 1.34%255.871.0%$316.40m
AAgilent Technologies, Inc. 5.07%130.131.6%$276.54m
BAXBaxter International, Inc. 0.29%75.971.8%$249.44m
MTDMettler-Toledo International, Inc. 4.66%1317.055.8%$205.68m

Company Profile

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.